D. Prieto-Alhambra

First name
D.
Last name
Prieto-Alhambra
Hawley, S., Leal, J., Delmestri, A., Prieto-Alhambra, D., Arden, N. K., Cooper, C., et al. (2016). Anti-Osteoporosis Medication Prescriptions and Incidence of Subsequent Fracture Among Primary Hip Fracture Patients in England and Wales: An Interrupted Time-Series Analysis. J Bone Miner Res. http://doi.org/10.1002/jbmr.2882
View
Judge, A., Garriga, C., Arden, N. K., Lovestone, S., Prieto-Alhambra, D., Cooper, C., & Edwards, C. J. (2017). Protective effect of antirheumatic drugs on dementia in rheumatoid arthritis patients. Alzheimers Dement (N Y). http://doi.org/10.1016/j.trci.2017.10.002
View
Yu, D., Jordan, K. P., Bedson, J., Englund, M., Blyth, F., Turkiewicz, A., et al. (2017). Population trends in the incidence and initial management of osteoarthritis: age-period-cohort analysis of the Clinical Practice Research Datalink, 1992-2013. Rheumatology (Oxford). http://doi.org/10.1093/rheumatology/kex270
View
Shah, A., Prieto-Alhambra, D., Hawley, S., Delmestri, A., Lippett, J., Cooper, C., et al. (2017). Geographic variation in secondary fracture prevention after a hip fracture during 1999-2013: a UK study. Osteoporos Int. http://doi.org/10.1007/s00198-016-3811-4
View
Bayliss, L. E., Culliford, D., Monk, A. P., Glyn-Jones, S., Prieto-Alhambra, D., Judge, A., et al. (2017). The effect of patient age at intervention on risk of implant revision after total replacement of the hip or knee: a population-based cohort study. Lancet. http://doi.org/10.1016/s0140-6736(17)30059-4
View
Leal, J., Gray, A. M., Hawley, S., Prieto-Alhambra, D., Delmestri, A., Arden, N. K., et al. (2017). Cost-Effectiveness of Orthogeriatric and Fracture Liaison Service Models of Care for Hip Fracture Patients: A Population-Based Study. J Bone Miner Res. http://doi.org/10.1002/jbmr.2995
View
Ferguson, R. J., Prieto-Alhambra, D., Walker, C., Yu, D., Valderas, J. M., Judge, A., et al. (2018). Validation of hip osteoarthritis diagnosis recording in the UK Clinical Practice Research Datalink. Pharmacoepidemiol Drug Saf. http://doi.org/10.1002/pds.4673
View
Burn, E., Edwards, C. J., Murray, D. W., Silman, A., Cooper, C., Arden, N. K., et al. (2018). Trends and determinants of length of stay and hospital reimbursement following knee and hip replacement: evidence from linked primary care and NHS hospital records from 1997 to 2014. BMJ Open. http://doi.org/10.1136/bmjopen-2017-019146
View
Martin-Merino, E., Petersen, I., Hawley, S., Alvarez-Gutierrez, A., Khalid, S., Llorente-Garcia, A., et al. (2018). Risk of venous thromboembolism among users of different anti-osteoporosis drugs: a population-based cohort analysis including over 200,000 participants from Spain and the UK. Osteoporos Int. http://doi.org/10.1007/s00198-017-4308-5
View
Garriga, C., Pazianas, M., Hawley, S., Delmestri, A., Prieto-Alhambra, D., Cooper, C., & Judge, A. (2018). Oral bisphosphonate use and age-related macular degeneration: retrospective cohort and nested case-control study. Ann N Y Acad Sci. http://doi.org/10.1111/nyas.13589
View